Cite
Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.
MLA
Elkhadragy, Lobna, et al. “Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.” Journal of Vascular & Interventional Radiology, vol. 33, no. 10, Oct. 2022, p. 1213. EBSCOhost, https://doi.org/10.1016/j.jvir.2022.07.011.
APA
Elkhadragy, L., Khabbaz, R. C., Muchiri, R. N., Totura, W. M., Samuelson, J. P., Whiteley, H. E., van Breemen, R. B., Lokken, R. P., & Gaba, R. C. (2022). Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model. Journal of Vascular & Interventional Radiology, 33(10), 1213. https://doi.org/10.1016/j.jvir.2022.07.011
Chicago
Elkhadragy, Lobna, Ramzy C. Khabbaz, Ruth N. Muchiri, William M. Totura, Jonathan P. Samuelson, Herbert E. Whiteley, Richard B. van Breemen, R. Peter Lokken, and Ron C. Gaba. 2022. “Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.” Journal of Vascular & Interventional Radiology 33 (10): 1213. doi:10.1016/j.jvir.2022.07.011.